Universite des Sciences et Technologies de Lille 1
6 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 4 name spellings.
5
Ending by 2030
Feb 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 23, 2026The maintenance fee for Method for ProNGF assay for in vitro diagnosis of cancer in particular breast, thyroid or lung cancer and therapeutic use of ProNGF (US 9,061,045) comes due Dec 23, 2026. Unpaid by Jun 23, 2027, it lapses early.
- 1 fee due Feb 1, 2027The maintenance fee for Carbon-Based Particles for Vapour Bubble Generation (US 11,712,484) comes due Feb 1, 2027. Unpaid by Aug 2, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 9 of 9
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,008,009 | Method for Prongf Assay for in Vitro Diagnosis of Cancer in Particular Breast, Thyroid or Lung Cancer and Therapeutic Use of Prongf In force · High confidence | In force | High confidence | |
| US 9,061,045 | Method for ProNGF assay for in vitro diagnosis of cancer in particular breast, thyroid or lung cancer and therapeutic use of ProNGF In force · From the USPTO record | In force | From the USPTO record | |
| US 8,328,977 | Method for Enhancing Adherence of Carbon Fibers with Respect to an Organic Matrix In force · High confidence | In force | High confidence | |
| US 8,906,403 | Biomaterials carrying cyclodextrins having improved absorption properties and used for the progressive and delayed release of therapeutic molecules In force · From the USPTO record | In force | From the USPTO record | |
| US 8,652,514 | Antimicrobial Peptides In force · High confidence | In force | High confidence | |
| US 10,254,275 | Device for Real-Time in Vivo Molecular Analysis In force · High confidence | In force | High confidence | |
| US 11,712,484 | Carbon-Based Particles for Vapour Bubble Generation In force · Medium confidence | In force | Medium confidence | |
| US 10,836,940 | Non-Flammable or Weakly Flammable Cooling Mixtures, Characterised by Low Relative Volatility for Two-Phase Heat-Exchange Systems In force · High confidence | In force | High confidence | |
| US 10,851,274 | Coolant Mixtures for Use in Heat-Exchange Devices in the Aerospace Field In force · High confidence | In force | High confidence |
Also on record, not counted in the 9: 6 patents in force now held by others · 25 lapsed for an unpaid fee · 8 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
4 abandoned · 4 no status recorded